| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/14/2002 | WO2002012268A1 Motor proteins and methods for their use |
| 02/14/2002 | WO2002012262A1 IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA |
| 02/14/2002 | WO2002011772A2 Radiolabelled metal transport proteins as imaging agents |
| 02/14/2002 | WO2002011769A1 Vascular endothelial growth factor 2 |
| 02/14/2002 | WO2002011762A2 Methods and compositions for modulating tumor growth |
| 02/14/2002 | WO2002011761A2 Vaccine against rsv |
| 02/14/2002 | WO2002011756A2 Anti-plasmodium compositions and methods of use |
| 02/14/2002 | WO2002011752A1 Use of gli1 gene |
| 02/14/2002 | WO2002011743A2 Treatment of prostate cancer |
| 02/14/2002 | WO2002011673A2 Methods of modulating activity of dxr |
| 02/14/2002 | WO2002011513A1 A novel polypeptide-human ehd protein 9.57 and the polynucleotide encoding said polypeptide |
| 02/14/2002 | WO2002011512A1 Novel polypeptide--the human mitochonrial cadherin 10.12 and polynucleotide encoding it |
| 02/14/2002 | WO2002011511A1 A novel polypeptide-the activating gtpase negative regulator 11.66 and the polynucleotide encoding said polypeptide |
| 02/14/2002 | WO2002011510A1 A novel polypeptide-human l1 motif-like orf2 protein 21 and the polynucleotide encoding said polypeptide |
| 02/14/2002 | WO2002005844A8 Protein complex serving as a vehicle for orally administerable medicaments |
| 02/14/2002 | WO2001092302A8 Human cyslt2 nucleic acids, polypeptides, and uses thereof |
| 02/14/2002 | WO2001081415A9 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 02/14/2002 | WO2001077319A3 Genetic manipulation of clostridium difficile |
| 02/14/2002 | WO2001073080A3 Recombinant iron uptake proteins |
| 02/14/2002 | WO2001073018A3 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 02/14/2002 | WO2001072838A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/14/2002 | WO2001070766A3 Therapeutic anti-cytomegalovirus compounds |
| 02/14/2002 | WO2001068670A3 Family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 02/14/2002 | WO2001064874A3 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/14/2002 | WO2001064835A8 Novel nucleic acids and polypeptides |
| 02/14/2002 | WO2001064834A8 Novel nucleic acids and polypeptides |
| 02/14/2002 | WO2001064243A3 Use of toxoplasma gondii mic3 protein as immunogenic agent |
| 02/14/2002 | WO2001064008A3 Vaccine for the treatment of artherosclerosis |
| 02/14/2002 | WO2001062926A3 44576, a novel g-protein coupled receptor and uses therefor |
| 02/14/2002 | WO2001059120A3 Il-17 like molecules and uses thereof |
| 02/14/2002 | WO2001059093A3 Full-length infectious cdna clones of tick borne flavivirus |
| 02/14/2002 | WO2001058951A3 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 02/14/2002 | WO2001058922A3 Method and compositions for treating hepatocellular cancer |
| 02/14/2002 | WO2001058921A3 Methods and compositions for generating angiostatin |
| 02/14/2002 | WO2001058915A3 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 02/14/2002 | WO2001058462A3 Models, methods and materials relating to clinical conditions associated with reactive oxygen species |
| 02/14/2002 | WO2001057210A3 Use of dendroaspin as a vehicle for non-dendroaspin domains |
| 02/14/2002 | WO2001057187A3 Novel bone marrow nucleic acids and polypeptides |
| 02/14/2002 | WO2001057183A3 Method for producing circular or multimeric protein species in vivo or in vitro and related methods |
| 02/14/2002 | WO2001056598A3 Methods for preventing or attenuating pathoangiogenic conditions by using gbs-toxin (cm101) |
| 02/14/2002 | WO2001055302A3 Nucleic acids, proteins, and antibodies |
| 02/14/2002 | WO2001053494A3 Cloning and overexpression vanadium bromoperoxidase from marine algae |
| 02/14/2002 | WO2001053472A3 Tumor and senescence marker |
| 02/14/2002 | WO2001049833A3 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
| 02/14/2002 | WO2001049705A3 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 02/14/2002 | WO2001048476A3 Extraction of biological components from body fluids |
| 02/14/2002 | WO2001047957A3 Human fgf-10- (kgf-2)-like protein zfgf-10 |
| 02/14/2002 | WO2001046419A3 Mammalian prion proteins; related reagents and methods |
| 02/14/2002 | WO2001042464A3 Human preoptic regulatory factor-2 and uses thereof |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | WO2001042287A3 Putative human g-protein coupled receptors |
| 02/14/2002 | WO2001038362A3 Production of vaccines |
| 02/14/2002 | WO2001034641A3 Antimicrobial activity of the first cationic cluster of human lactoferrin |
| 02/14/2002 | WO2001032695A3 MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF |
| 02/14/2002 | WO2001021771A3 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 02/14/2002 | WO2001014418A3 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 02/14/2002 | WO2000073337A9 Polymer conjugates of hedgehog proteins and uses |
| 02/14/2002 | WO2000068258A3 Compounds exhibiting an antibiotic activity |
| 02/14/2002 | WO2000066143A9 Secreted proteins of mycobacterium tuberculosis and their use as vaccines and diagnostic reagents |
| 02/14/2002 | WO2000065063A9 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 02/14/2002 | WO2000065062A3 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 02/14/2002 | WO2000044908A9 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 02/14/2002 | WO2000009552A9 Secreted proteins and polynucleotides encoding them |
| 02/14/2002 | WO1997020938A3 Cells with hybrid receptor and gene construct which can be controlled by said hybrid receptor, and use of said cells in gene therapy |
| 02/14/2002 | US20020019996 Nucleotide sequences associated with response to gravity in plants; for use in the generation of plant organs |
| 02/14/2002 | US20020019995 Nod factor binding protein from legume roots |
| 02/14/2002 | US20020019992 Transgenic non-human mammals with progressive neurologic disease |
| 02/14/2002 | US20020019520 CBFBGA09: a human SL15 homolog |
| 02/14/2002 | US20020019518 A sublancin peptide variant (lantibody) having a spacer region and a subtilin leader peptide to provide an anchoring means for inserting and retaining the lantibody in a host cell wall; genetic engineering; bactericides; viricides; kits |
| 02/14/2002 | US20020019517 Fibronectins for use as diagnostic and treatment tools in gene therapy |
| 02/14/2002 | US20020019516 Cross-linked collagen matrices and methods for their preparation |
| 02/14/2002 | US20020019515 Novel spoIIIE |
| 02/14/2002 | US20020019514 Nucleotide sequences coding fusion protein for use in the detection and treatment of diabetes, autoimmune disease and arthritis |
| 02/14/2002 | US20020019362 Treatment of tumors with genetically engineered herpes virus |
| 02/14/2002 | US20020019359 Oligonucleotide with a base sequence complementary to a target portion of a nucleic acid encoding angiogenin |
| 02/14/2002 | US20020019352 Stable, active, human ob protein compositions and methods |
| 02/14/2002 | US20020019350 Targeted angiogenesis |
| 02/14/2002 | US20020019348 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/14/2002 | US20020019347 Amino acid sequences of the peptides |
| 02/14/2002 | US20020019343 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol |
| 02/14/2002 | US20020019342 In vitro modification of glycosylation patterns of recombinant glycopeptides |
| 02/14/2002 | US20020019337 Treatment of fruits or vegetables with hypersensitive response elicitor to inhibit postharvest disease or desiccation |
| 02/14/2002 | US20020019331 Enhancing an immune response to a human self tumor antigen, by immunizing a human being with a foreign protein homologous to human self tumor antigen which is a protein expression product of an overexpressed human oncogene |
| 02/14/2002 | US20020019052 FACS assisted methods for introducing individual chromosomes into cells |
| 02/14/2002 | US20020019043 Treating inflammatory bowel disease in humans; obtain human, administer drug, monitor for reduction in side effects from gastrointestinal disorder |
| 02/14/2002 | US20020019040 Apoptin-associating protein |
| 02/14/2002 | US20020019039 A chemically modified mutant protein, e.g. an enzyme, having a substituted cysteine reacted with a glyosyslated thiosulfate; high esterase activity and low amidase activity of subtilisins; protease to degrade lectins |
| 02/14/2002 | US20020019036 Antihemophilic protein; for use in diagnosis and treatment of autoimmune diseases and blood disorders |
| 02/14/2002 | US20020019033 Polynucleotides encoding chemokine beta-15 |
| 02/14/2002 | US20020019032 Nucleotide sequences coding polypetide for use in the diagnosis and treatment of nervous system, psychological, sexual, circadian rhythms, eating, glandular, sleep disorders, pain and neuropathic pain |
| 02/14/2002 | US20020019029 Protein; for use in the treatment of cancer, cardiovascular disorders and nervous system disorders |
| 02/14/2002 | US20020019028 Peptide; for use in the treatment of defects associated with polypeptide transfer |
| 02/14/2002 | US20020019027 Protein for use in the prevention and treatment of cancer; antitumor agents; anticarcinogenic agents |
| 02/14/2002 | US20020019026 Nucleotide sequences coding preferential polypeptide for use in te detection and treatment of cancer, psychological and nervous system disorders; for use in gene therapy |
| 02/14/2002 | US20020019025 Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography |
| 02/14/2002 | US20020019020 Methods for treating cardiovascular disorders |
| 02/14/2002 | US20020019008 Administering to the mammal a formulation comprising a an SMR1 (submandibular rat protein) protein, or its maturation product or derivatives to prevent or treat the diseases caused by mineral ion imbalance |
| 02/14/2002 | US20020019000 Polynucleotides coexpressed with matrix-remodeling genes |
| 02/14/2002 | US20020018995 Detecting brain disorders; obtain sample tissue, monitor tau mutant isoform duplications in cell, compare to wild type, amplification in tau mutant isoforms indicates brain disorders |
| 02/14/2002 | US20020018990 Reagents and methods useful for detecting diseases of the breast |